Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001102624-13-000430
Filing Date
2013-04-04
Accepted
2013-04-04 16:05:59
Documents
12
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 BOSTON THERAPEUTICS, INC. 10-K bostontherapeutics10k.htm 10-K 1125652
2 EXHIBIT 23.1 exh23_1.htm EX-23.1 2870
3 EXHIBIT 31.1 exh31_1.htm EX-31.1 19246
4 EXHIBIT 31.2 exh31_2.htm EX-31.2 19056
5 EXHIBIT 32.1 exh32_1.htm EX-32.1 8692
6 EXHIBIT 32.2 exh32_2.htm EX-32.2 8408
  Complete submission text file 0001102624-13-000430.txt   3531495

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT bstn-20121231.xml EX-101.INS 321415
8 XBRL TAXONOMY EXTENSION SCHEMA bstn-20121231.xsd EX-101.SCH 32633
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bstn-20121231_cal.xml EX-101.CAL 35037
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bstn-20121231_def.xml EX-101.DEF 53550
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE bstn-20121231_lab.xml EX-101.LAB 210778
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bstn-20121231_pre.xml EX-101.PRE 146837
Mailing Address 33 SOUTH COMMERCIAL STREET MANCHESTER NH 03101
Business Address 33 SOUTH COMMERCIAL STREET MANCHESTER NH 03101 978-886-0421
Boston Therapeutics, Inc. (Filer) CIK: 0001473579 (see all company filings)

EIN.: 270801073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-54586 | Film No.: 13743245
SIC: 2834 Pharmaceutical Preparations